Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 2
1991 2
1992 1
1993 2
1994 1
1997 1
1998 1
1999 3
2001 3
2002 2
2003 4
2004 5
2005 4
2006 14
2007 6
2008 14
2009 14
2010 7
2011 14
2012 16
2013 18
2014 27
2015 21
2016 24
2017 16
2018 21
2019 18
2020 23
2021 30
2022 31
2023 31
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

343 results

Results by year

Filters applied: . Clear all
Page 1
Age-related macular degeneration.
Guymer RH, Campbell TG. Guymer RH, et al. Lancet. 2023 Apr 29;401(10386):1459-1472. doi: 10.1016/S0140-6736(22)02609-5. Epub 2023 Mar 27. Lancet. 2023. PMID: 36996856 Review.
Age-related macular degeneration.
Fleckenstein M, Keenan TDL, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, Wong WT, Chew EY. Fleckenstein M, et al. Among authors: guymer rh. Nat Rev Dis Primers. 2021 May 6;7(1):31. doi: 10.1038/s41572-021-00265-2. Nat Rev Dis Primers. 2021. PMID: 33958600 Review.
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants.
Fritsche LG, Igl W, Bailey JN, Grassmann F, Sengupta S, Bragg-Gresham JL, Burdon KP, Hebbring SJ, Wen C, Gorski M, Kim IK, Cho D, Zack D, Souied E, Scholl HP, Bala E, Lee KE, Hunter DJ, Sardell RJ, Mitchell P, Merriam JE, Cipriani V, Hoffman JD, Schick T, Lechanteur YT, Guymer RH, Johnson MP, Jiang Y, Stanton CM, Buitendijk GH, Zhan X, Kwong AM, Boleda A, Brooks M, Gieser L, Ratnapriya R, Branham KE, Foerster JR, Heckenlively JR, Othman MI, Vote BJ, Liang HH, Souzeau E, McAllister IL, Isaacs T, Hall J, Lake S, Mackey DA, Constable IJ, Craig JE, Kitchner TE, Yang Z, Su Z, Luo H, Chen D, Ouyang H, Flagg K, Lin D, Mao G, Ferreyra H, Stark K, von Strachwitz CN, Wolf A, Brandl C, Rudolph G, Olden M, Morrison MA, Morgan DJ, Schu M, Ahn J, Silvestri G, Tsironi EE, Park KH, Farrer LA, Orlin A, Brucker A, Li M, Curcio CA, Mohand-Saïd S, Sahel JA, Audo I, Benchaboune M, Cree AJ, Rennie CA, Goverdhan SV, Grunin M, Hagbi-Levi S, Campochiaro P, Katsanis N, Holz FG, Blond F, Blanché H, Deleuze JF, Igo RP Jr, Truitt B, Peachey NS, Meuer SM, Myers CE, Moore EL, Klein R, Hauser MA, Postel EA, Courtenay MD, Schwartz SG, Kovach JL, Scott WK, Liew G, Tan AG, Gopinath B, Merriam JC, Smith RT, K… See abstract for full author list ➔ Fritsche LG, et al. Among authors: guymer rh. Nat Genet. 2016 Feb;48(2):134-43. doi: 10.1038/ng.3448. Epub 2015 Dec 21. Nat Genet. 2016. PMID: 26691988 Free PMC article.
Reply.
Guymer RH, Wu Z, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Luu CD; LEAD Study Group. Guymer RH, et al. Ophthalmology. 2019 Dec;126(12):e92-e93. doi: 10.1016/j.ophtha.2019.07.017. Ophthalmology. 2019. PMID: 31759505 No abstract available.
Reply.
Goh KL, Chen FK, Balaratnasingam C, Abbott CJ, Hodgson LAB, Guymer RH, Wu Z. Goh KL, et al. Among authors: guymer rh. Ophthalmology. 2022 Oct;129(10):e150-e151. doi: 10.1016/j.ophtha.2022.06.010. Epub 2022 Jul 19. Ophthalmology. 2022. PMID: 35863962 No abstract available.
A clinician's guide to network meta-analysis.
Phillips MR, Steel DH, Wykoff CC, Busse JW, Bannuru RR, Thabane L, Bhandari M, Chaudhary V; Retina Evidence Trials InterNational Alliance (R.E.T.I.N.A.) Study Group. Phillips MR, et al. Eye (Lond). 2022 Aug;36(8):1523-1526. doi: 10.1038/s41433-022-01943-5. Epub 2022 Feb 10. Eye (Lond). 2022. PMID: 35145277 Free PMC article. No abstract available.
What makes a good survey?
Chang Y, Wang L, Phillips MR, Wykoff CC, Garg SJ, Thabane L, Bhandari M, Chaudhary V; Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group. Chang Y, et al. Eye (Lond). 2023 Nov;37(16):3299-3301. doi: 10.1038/s41433-023-02518-8. Epub 2023 Apr 7. Eye (Lond). 2023. PMID: 37029303 No abstract available.
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Among authors: guymer rh. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Noninferiority randomised trials in ophthalmology.
Kim K, Zeraatkar D, Pitre TS, Phillips M, Wykoff CC, Garg SJ, Guymer RH, Thabane L, Bhandari M, Chaudhary V; Retina Evidence and Trials INternational Alliance (R.E.T.I.N.A.) Study Group. Kim K, et al. Among authors: guymer rh. Eye (Lond). 2023 Oct;37(15):3059-3060. doi: 10.1038/s41433-023-02465-4. Epub 2023 Mar 3. Eye (Lond). 2023. PMID: 36869135 No abstract available.
343 results